Amyris Collaborates with Firmenich to Develop Disruptive Bio-Based Fragrance Ingredient

Consumer Products
by
|
May 3, 2018

EMERYVILLE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner, Firmenich, to support the development and commercialization of Z11. This sustainable and cost-effective version of Firmenich's iconic Z11 molecule was developed using Amyris's disruptive proprietary technology to develop a reliable and sustainable supply of an intermediate, using a fermentation-based production process, for which Firmenich has then applied its state of the art, proprietary green chemistry.

"We are pleased with our ability to support Firmenich's product innovation as they continue to be a leader in developing game-changing ingredients for their customers," said John Melo, President & CEO of Amyris. "Amyris has collaborated with Firmenich since 2010, successfully growing a palette of bio-based fragrance ingredients and intermediates as Firmenich continues their legacy of providing the finest ingredients well into the future, with the added benefit of being derived from a sustainable resource."About AmyrisAmyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.Amyris and the Amyris logo are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries. All other trademarks are the property of their respective owners.Contact:Peter DeNardoDirector, Investor Relations and Corporate CommunicationsAmyris, Inc.+1 (510) 740-7481investor@amyris.compr@amyris.comSource: http://investors.amyris.com/releasedetail.cfm?ReleaseID=1066150

Related Articles

No items found.

Amyris Collaborates with Firmenich to Develop Disruptive Bio-Based Fragrance Ingredient

by
May 3, 2018

Amyris Collaborates with Firmenich to Develop Disruptive Bio-Based Fragrance Ingredient

by
May 3, 2018

EMERYVILLE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner, Firmenich, to support the development and commercialization of Z11. This sustainable and cost-effective version of Firmenich's iconic Z11 molecule was developed using Amyris's disruptive proprietary technology to develop a reliable and sustainable supply of an intermediate, using a fermentation-based production process, for which Firmenich has then applied its state of the art, proprietary green chemistry.

"We are pleased with our ability to support Firmenich's product innovation as they continue to be a leader in developing game-changing ingredients for their customers," said John Melo, President & CEO of Amyris. "Amyris has collaborated with Firmenich since 2010, successfully growing a palette of bio-based fragrance ingredients and intermediates as Firmenich continues their legacy of providing the finest ingredients well into the future, with the added benefit of being derived from a sustainable resource."About AmyrisAmyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.Amyris and the Amyris logo are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries. All other trademarks are the property of their respective owners.Contact:Peter DeNardoDirector, Investor Relations and Corporate CommunicationsAmyris, Inc.+1 (510) 740-7481investor@amyris.compr@amyris.comSource: http://investors.amyris.com/releasedetail.cfm?ReleaseID=1066150

RECENT INDUSTRY NEWS
RECENT INSIGHTS
Sign Up Now